Literature DB >> 28941723

AEG-1 mRNA expression in non-small cell lung cancer is associated with increased tumor angiogenesis.

Zhihong Ma1, Yingrong Chen1, Shunli Dong1, Xuting Xu1, Jin Liu2, Pengtao Song2, Caihua Yu3, Licheng Dai4.   

Abstract

Astrocyte-elevated gene-1 (AEG-1) is implicated in the oncogenesis and angiogenesis of various types of human malignant disease. However, the angiogenesis roles of AEG-1 in non-small cell lung cancer (NSCLC) remain to be further elucidated. In the present study, the expression level of AEG-1 mRNA in seven human lung cell lines and 89 paired tissue samples (tumor tissues (TTs) and pair-matched normal adjacent tissues (PMNATs)) from NSCLC patients was detected by real-time PCR. Staining of vascular endothelial growth factor (VEGF) and intratumoral microvessel density (iMVD, labeled by CD105) were assessed by immunohistochemistry. Furthermore, cell migration and invasion were evaluated by wound healing assay and transwell assays. AEG-1 mRNA level was significantly higher in human lung cancer cells and TTs than that in human normal bronchial epithelial cell line 16HBE and PMNATs, respectively (P<0.001). Higher AEG-1 mRNA level in patients with NSCLC was correlated with clinical stages (P=0.028), differentiation (P=0.042), and lymph node metastasis (P=0.004). Moreover, Upregulated AEG-1 mRNA expression level was associated with higher tumor angiogenesis, reflected by the increase of VEGF expression and iMVD counting (P=0.021, P<0.001). However, 95D cell line transfected with AEG-1 siRNA oligos (siAEG-1) exhibited no significant decrease of cell invasion or migration capacities when compared with the control cells (P>0.05).These results suggested that AEG-1 may play important roles at the transcription level in malignant transformation and tumor angiogenesis in NSCLC, and anti-AEG-1 mRNA expression may be a novel potential strategy for anti-angiogenic therapy of NSCLC.
Copyright © 2017 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  AEG-1; Angiogenesis; Immunohistochemistry; Intratumoral microvessel density; Non-small cell lung cancer

Mesh:

Substances:

Year:  2017        PMID: 28941723     DOI: 10.1016/j.prp.2017.09.003

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  5 in total

1.  Prognostic and clinicopathologic significance of AEG-1/MTDH and E-cadherin expression in human gallbladder carcinoma.

Authors:  Song-Tao Xu; Yong-Chao Ma; Cai-Hong Wang; Yue Xu; Guo-Jian Gu
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

2.  Clinical significance and effect of MTDH/AEG-1 in bladder urothelial cancer: a study based on immunohistochemistry, RNA-seq, and in vitro verification.

Authors:  Yu Zhang; Li-Jie Zhang; Yi-Wu Dang; Sheng-Hua Li; Hai-Biao Yan; Gang Chen
Journal:  Cancer Manag Res       Date:  2018-12-14       Impact factor: 3.989

3.  MicroRNA-618 Directly Targets Metadherin mRNA To Suppress The Malignant Phenotype Of Osteosarcoma Cells By Reducing PTEN-AKT Pathway Output.

Authors:  Bohan Li; Jie Zhao; Qian Zhao; Dongjin Wu; Cheng Zhang; Kun Zhao; Yang Song; Chunzheng Gao
Journal:  Onco Targets Ther       Date:  2019-11-15       Impact factor: 4.147

Review 4.  Novel Angiogenic Regulators and Anti-Angiogenesis Drugs Targeting Angiogenesis Signaling Pathways: Perspectives for Targeting Angiogenesis in Lung Cancer.

Authors:  Yingying Li; Mengmeng Lin; Shiyuan Wang; Bo Cao; Chunyu Li; Guohui Li
Journal:  Front Oncol       Date:  2022-03-16       Impact factor: 6.244

Review 5.  Cancer Angiogenesis and Opportunity of Influence on Tumor by Changing Vascularization.

Authors:  Igor Maiborodin; Alfija Mansurova; Alexander Chernyavskiy; Alexander Romanov; Vladimir Voitcitctkii; Anna Kedrova; Alexander Tarkhov; Alena Chernyshova; Sergey Krasil'nikov
Journal:  J Pers Med       Date:  2022-02-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.